TOP2A and neoplasm: ERBB2 DNA and RNA (ICD and ECD) and TOP2α DNA and RNA status: (+ increased, = maintained and – decreased) considering the cut-off 2-fold and ERBB2 protein status following the 2013 ASCO/CAP guidelines (and maintained in the 2018 recommendations) of each of each tumor sample.